Sotera Health

Sotera Health FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of Sotera Health (SHC) as of Nov 19, 2026 is 191.38 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 101.57 % — a change of 88.42% (higher).

FCF Conversion

191.38 %

YoY

88.42%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Sotera Health is 2025 191.38 % . FCF Conversion Rate (FCF/EBITDA) of Sotera Health was 2024 101.57 % . It decreases by 88.42% higher compared to the previous year.

The Sotera Health FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2018
-799.83 USD
Jan 1, 2019
-440.21 USD
Jan 1, 2020
-173.70 USD
Jan 1, 2021
153.47 USD
Jan 1, 2022
-40.92 USD
Jan 1, 2023
-705.99 USD
Jan 1, 2024
101.57 USD
Jan 1, 2025
191.38 USD
The Sotera Health FCF Conversion history
YEARFCF ConversionYoY
191.38 %+88.42%
101.57 %-114.39%
-705.99 %+1,625.17%
-40.92 %-126.66%
153.47 %-188.36%
-173.70 %-60.54%
-440.21 %-44.96%
-799.83 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Sotera Health Stock analysis

What does Sotera Health do? Sotera Health Co is an American company specializing in the manufacturing and distribution of products and services in the medical industry. It was founded in 2017 through the merger of three companies: Nordion, Sterigenics, and Nelson Labs. Nordion, originally a Canadian company, focused on antibiotic and cancer research and became a leader in the production of radioactive isotopes in the 1960s. Sterigenics, established in the 1980s, was one of the first companies specializing in dose sterilization of medical devices. Nelson Labs was a laboratory and consulting firm focused on product and service safety in the food, pharmaceutical, and medical industries. Sotera Health Co's business model is centered around improving patient health and well-being by ensuring the safety and reliability of products and services in the medical industry. The company offers various services such as medical sterilization, equipment cleaning and testing, and packaging processes. Additionally, it provides comprehensive consulting to ensure compliance with regulations. Sotera Health is divided into three business segments: Sterigenics, Nordion, and Nelson Labs. Sterigenics is the largest company within Sotera Health, specializing in the sterilization and disinfection of medical devices, packaging, and equipment. Nordion leads in providing radioactive isotopes and technologies for medical research, diagnostics, and therapy. Nelson Labs specializes in the analysis of products, safety, and stability, offering a wide range of testing and consulting services for various industries. To provide comprehensive service to its customers, Sotera Health has developed a variety of products and services. For example, it offers technological solutions to simplify the sterilization of medical instruments and packaging, including automated sterilization processes and specialized solutions for complex medical instruments. The company also provides quality assurance services, including inspections and audits, to ensure compliance with regulations. Overall, Sotera Health plays a key role in the medical industry by ensuring the safety and reliability of products and services for use by patients and medical professionals. The company successfully meets the needs of its customers and finds effective solutions for complex medical challenges. With its focus on quality and safety, Sotera Health Co has established itself as an innovative and reliable provider in the medical industry. Answer: Sotera Health Co is an American company specializing in the manufacturing and distribution of products and services in the medical industry. It was founded in 2017 through the merger of three companies: Nordion, Sterigenics, and Nelson Labs. It provides services such as medical sterilization, equipment testing, and consulting to ensure compliance with regulations. Sotera Health is divided into three business segments: Sterigenics, Nordion, and Nelson Labs. It offers technological solutions for sterilization and quality assurance. Overall, Sotera Health plays a key role in the medical industry by ensuring the safety and reliability of products and services. Sotera Health is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Sotera Health stock

FCF Conversion Rate (FCF/EBITDA) of Sotera Health is 191.38 % in 2025.

FCF Conversion Rate (FCF/EBITDA) of Sotera Health changed from 101.57 % to 191.38 %, representing a 88.42% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Sotera Health since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Sotera Health with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Sotera Health

All Key Metrics — Sotera Health